An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, ...

A groundbreaking new study suggests that prostate cancer treatment may soon become faster, simpler, and less disruptive for ...

An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, ...

Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, prostate cancer often comes with traditional treatments that cause difficult ...

Discusses Extended Follow-Up Data From Phase 3 Trial of aglatimagene besadenovec in Localized Prostate Cancer May 15, ...

A newly developed targeted radiopharmaceutical treatment can effectively slow tumor growth in pancreatic ductal ...

Ugandan cancer specialists have warned of shifting cancer trends, reflecting a mix of declining infection-related cancers ...

EpCAM-targeted immunotherapies represent a key opportunity in treating epithelial tumors due to high expression in cancers but face challenges from off-tumor toxicities. Advances in conditional ...

The main market opportunities lie in PSMA-targeted therapies and radiodiagnostics, which are proving commercially successful for PET imaging and treatment of prostate cancer. Growth potential exists ...

Researchers Moffitt Cancer Center have reported encouraging early results from a clinical trial testing whether immunotherapy can improve treatment for men with one of the most dangerous forms of ...

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.